MedTrace Logo

Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery

NCT02601495 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-08-14

No results posted yet for this study

Summary

In this study the investigators will seek to improve their understanding of how positive and negative valence systems, cognition, and arousal/interoception are inter-related in disorders of trauma, mood, substance use, and eating behavior for women involved in a court diversion program in Tulsa, Oklahoma (Women in Recovery). The investigators will recruit 100 individuals and use a wide range of assessment tools, neuroimaging measures, blood and microbiome collections and behavioral tasks to complete the baseline and follow-up study visits. Upon completion, the investigators aim to have robust and reliable dimensional measures that quantify these systems and a set of assessments that should be recommended as a clinical tool to enhance outcome prediction for the clinician and assist in determining who will likely benefit from the diversion program, and to inform future revision or augmentation of the program to increase treatment effectiveness.

Conditions

Interventions

BEHAVIORAL

Women in a court diversion program

Women in Recovery (WIR) is an intensive outpatient alternative for eligible women facing long prison sentences for non-violent, drug-related offenses in Oklahoma.

Sponsors & Collaborators

  • University of Oklahoma

    collaborator OTHER

  • Rutgers University

    collaborator OTHER

  • University of California, San Diego

    collaborator OTHER

  • Laureate Institute for Brain Research, Inc.

    lead OTHER

Principal Investigators

  • Martin P. Paulus, M.D. · Laureate Institute for Brain Research

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2020-01-31
Completion
2028-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02601495 on ClinicalTrials.gov